Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-05-01

FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for mesalamine submitted by Zydus Lifesciences Limited, typically indicating a labeling update or related change to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)